Creator: Dr. Tran Le, MD, DABOM
Published: 2026-06-22T14:07:17+00:00

GLP-1 medications get most of the attention right now, but they aren't the only effective tools, and they aren't right for everyone. For some patients, an older, well-understood oral medication is the better starting point.

This is a clinical decision, so our program is physician-led by Dr. Tran Le, MD, DABOM. She is triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine.

Phentermine and oral weight-loss options: when a non-GLP-1 fits

The best weight-loss medication matches your biology, your other health conditions, your budget, and what you can stick with. Major obesity guidelines agree: the selection of the medication should be based on the clinical profile and needs of the patient, including comorbidities, patients' preferences, costs, and access to the therapy.

The American Association of Clinical Endocrinology likewise recommends individualizing the choice of pharmacotherapy based on obesity-related conditions, comorbidities, and potential adverse events.

An oral, non-GLP-1 option is often the right fit when a patient wants to avoid injections, when cost or access is a barrier, when a GLP-1 isn't tolerated or appropriate, or when the goal is a shorter-term jump-start alongside diet and activity changes.

How phentermine actually works

Phentermine is one of the oldest prescription weight-loss medications still in use. It was approved in 1959 by the FDA as an adjunct to diet. It's an appetite suppressant. Its action appears to be related to stimulation of the hypothalamus to release norepinephrine, resulting in reduced appetite. It turns down hunger signals so a reduced-calorie plan feels more doable.

Phentermine is FDA approved for short-term use (up to 12 weeks), and it works best alongside a reduced-calorie diet plan and regular exercise. It's also a stimulant, so timing matters. To avoid trouble sleeping, the last dose of the day is usually taken about 4 to 6 hours before bedtime.

Other oral options beyond phentermine

Two other non-injectable options come up often.

Phentermine/topiramate

Combining phentermine with topiramate targets appetite through more than one pathway. These include reducing appetite through inhibition of norepinephrine reuptake (phentermine) and reduction of hypothalamic glutamate neurotransmission (topiramate), enhancing satiety, and increasing energy expenditure. This combination was approved by the FDA in 2012 for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition.

In meta-analysis, it has performed strongly among oral agents. Phentermine/topiramate ER currently appears to be the most effective available oral obesity pharmacotherapy, although longer-term data are required.

Naltrexone/bupropion

This combination works on appetite and reward, not as a stimulant. Its proposed mechanism involves complementary stimulation of central melanocortin pathways, resulting in increased energy expenditure and reduced appetite, with effects on the hypothalamus (the appetite regulatory center) and the mesolimbic dopamine circuit (the reward system). It was approved by the FDA in September 2014 to treat obesity. It can fit patients whose eating is driven by cravings and reward.

Read more on our oral medications page, or see how it works.

When a GLP-1 is usually the better choice

Non-GLP-1 doesn't mean "always first." For many patients, especially those with type 2 diabetes, guideline bodies lean toward incretin therapy (treatments that mimic gut hormones). For people with diabetes and overweight or obesity, the ADA recommends as preferred pharmacotherapy a GLP-1 receptor agonist or a dual GLP-1/GIP receptor agonist with substantial weight-loss efficacy.

We offer GLP-1 options too. These include all-inclusive compounded semaglutide and tirzepatide, plus an à la carte plan for brand-name GLP-1s like Wegovy, Ozempic, Zepbound, and Mounjaro. (Compounded medications are not FDA-approved.) See the medications overview and pricing for details.

Who should be cautious with phentermine

Because phentermine raises sympathetic tone, it isn't right for everyone. Cardiovascular contraindications for the use of phentermine include a history of coronary artery disease, stroke, arrhythmias, congestive heart failure, and uncontrolled hypertension. More broadly, phentermine is contraindicated in patients with advanced arteriosclerosis, hyperthyroidism, moderate to severe hypertension, symptomatic cardiovascular disease, agitated states, a history of drug abuse, or glaucoma, and also within 14 days of taking monoamine oxidase inhibitors (MAOIs).

Rare reports also link it to coronary issues. A Mayo Clinic Proceedings series noted that phentermine may have vasospastic properties that are important to consider when prescribing.

Phentermine is not dangerous when prescribed appropriately, which is why the evaluation matters. We review your cardiac history, blood pressure, medications, and goals before prescribing anything. This article is educational and isn't a substitute for that personal evaluation.

Frequently asked questions

Is phentermine less effective than a GLP-1?

They work differently, and the research isn't a simple head-to-head ranking. The better question is which fits your health profile, tolerance, and goals. For patients with diabetes, guidelines often favor a GLP-1. For others, an oral agent may be a sensible, lower-cost starting point. The physician decides with you.

How long can I take phentermine?

Phentermine is FDA approved for short-term use (up to 12 weeks). The phentermine/topiramate combination, by contrast, was approved by the FDA in 2012 for long-term weight management. Your prescriber will set a plan based on your response and health.

Do oral medications still require diet and exercise?

Yes. These medications are intended to be used alongside lifestyle changes. They make the work more achievable and do not replace it.

Talk to a physician about the right fit

If you're weighing phentermine and oral weight-loss options against a GLP-1, the next step is a clinical conversation. Our Texas- and Utah-based program is physician-led by Dr. Le. We'll match the plan to you, including a Medicare GLP-1 bridge option where it applies. Start your consultation here.

Phentermine & Oral Weight-Loss Options: When a Non-GLP-1 Fits